Guardant Health
GH
#1546
Rank
HK$108.91 B
Marketcap
HK$838.63
Share price
-2.36%
Change (1 day)
182.70%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -HK$25.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$25.03. In 2024 the company made an earnings per share (EPS) of -HK$27.75 an increase over its 2023 EPS that were of -HK$33.37.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$25.02-9.87%
2024-HK$27.75-16.82%
2023-HK$33.37-33.13%
2022-HK$49.9060%
2021-HK$31.1855.04%
2020-HK$20.11207.14%
2019-HK$6.55-19.81%
2018-HK$8.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-HK$16.68-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-HK$37.48 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA